CN101583355A - 用于在肥胖患者中预防和治疗高血压的肾素抑制剂 - Google Patents

用于在肥胖患者中预防和治疗高血压的肾素抑制剂 Download PDF

Info

Publication number
CN101583355A
CN101583355A CNA2007800499179A CN200780049917A CN101583355A CN 101583355 A CN101583355 A CN 101583355A CN A2007800499179 A CNA2007800499179 A CN A2007800499179A CN 200780049917 A CN200780049917 A CN 200780049917A CN 101583355 A CN101583355 A CN 101583355A
Authority
CN
China
Prior art keywords
hypertension
obese patient
renin inhibitor
alkyl
body mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800499179A
Other languages
English (en)
Chinese (zh)
Inventor
M·F·普雷斯科特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39186152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101583355(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN101583355A publication Critical patent/CN101583355A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2007800499179A 2006-12-15 2007-12-13 用于在肥胖患者中预防和治疗高血压的肾素抑制剂 Pending CN101583355A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018006P 2006-12-15 2006-12-15
US60/870,180 2006-12-15

Publications (1)

Publication Number Publication Date
CN101583355A true CN101583355A (zh) 2009-11-18

Family

ID=39186152

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800499179A Pending CN101583355A (zh) 2006-12-15 2007-12-13 用于在肥胖患者中预防和治疗高血压的肾素抑制剂

Country Status (18)

Country Link
US (1) US20100029775A1 (cg-RX-API-DMAC7.html)
EP (1) EP2094259A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010513300A (cg-RX-API-DMAC7.html)
KR (1) KR20090090384A (cg-RX-API-DMAC7.html)
CN (1) CN101583355A (cg-RX-API-DMAC7.html)
AU (1) AU2007333095B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0721167A2 (cg-RX-API-DMAC7.html)
CA (1) CA2672579A1 (cg-RX-API-DMAC7.html)
CL (1) CL2007003628A1 (cg-RX-API-DMAC7.html)
IL (1) IL198876A0 (cg-RX-API-DMAC7.html)
MA (1) MA31003B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009006340A (cg-RX-API-DMAC7.html)
NO (1) NO20092597L (cg-RX-API-DMAC7.html)
RU (1) RU2009126741A (cg-RX-API-DMAC7.html)
TN (1) TN2009000240A1 (cg-RX-API-DMAC7.html)
TW (1) TW200831071A (cg-RX-API-DMAC7.html)
WO (1) WO2008074001A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903442B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143425A1 (de) * 2008-07-11 2010-01-13 Ratiopharm GmbH Direktverpresste Aliskiren-Tabletten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
TW200538154A (en) * 2004-02-17 2005-12-01 Novartis Ag Combination of organic compounds
RU2426532C2 (ru) * 2004-03-17 2011-08-20 Новартис Аг Применение органических соединений
WO2007047351A2 (en) * 2005-10-13 2007-04-26 Orexigen Therapeutics, Inc. Methods for treating hypertension in overweight and obese individuals
CA2655144A1 (en) * 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method

Also Published As

Publication number Publication date
US20100029775A1 (en) 2010-02-04
ZA200903442B (en) 2010-05-26
KR20090090384A (ko) 2009-08-25
MX2009006340A (es) 2009-06-23
CL2007003628A1 (es) 2008-07-18
MA31003B1 (fr) 2009-12-01
NO20092597L (no) 2009-07-13
EP2094259A1 (en) 2009-09-02
TN2009000240A1 (en) 2010-10-18
RU2009126741A (ru) 2011-01-20
CA2672579A1 (en) 2008-06-19
BRPI0721167A2 (pt) 2014-03-18
TW200831071A (en) 2008-08-01
AU2007333095A1 (en) 2008-06-19
JP2010513300A (ja) 2010-04-30
AU2007333095B2 (en) 2011-03-24
WO2008074001A8 (en) 2009-07-02
WO2008074001A1 (en) 2008-06-19
IL198876A0 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
CN101518650A (zh) Dpp iv抑制剂和心血管化合物的组合
EP2305232B1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
AU2005224014B9 (en) Use of organic compounds
US20040087484A1 (en) Combination of organic compounds
CN101166523A (zh) 治疗动脉粥样硬化的方法
JP2010508370A (ja) ヘミフマル酸アリスキレンの結晶形
CN101300030A (zh) 血管紧张素ⅱ受体阻滞剂、钙通道阻滞剂和另一活性物质的组合产品
AU2007234917B2 (en) Renin inhibitors for the treatment of hypertension
AU2007333095B2 (en) Renin inhibitors for the prevention and treatment of hypertension in obese patients
AU2007203210B2 (en) Combination of a DPP IV inhibitor and a cardiovascular compound
HK1155097B (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091118